Related references
Note: Only part of the references are listed.Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging
Junko Ochi et al.
JAPANESE JOURNAL OF RADIOLOGY (2010)
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2009)
Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2007)
Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea - A report from the Korean Breast Cancer Society
Sei Hyun Ahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adjuvant endocrine therapy for premenopausal women with early breast cancer
Ting Bao et al.
BREAST CANCER RESEARCH (2007)
Toremifene: An evaluation of its safety profile
Harold A. Harvey et al.
BREAST (2006)
A double-blind randomized controlled trial of toremifen therapy for mastalgia
C Gong et al.
ARCHIVES OF SURGERY (2006)
Bone mineral density and lipid changes during 5 years of follow-up in a study of prevention of breast cancer with toremifene in healthy, high-risk pre- and post-menopausal women
R Erkkola et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma
N Kroman et al.
CANCER (2004)
Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy
A Sverrisdóttir et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene
A Tiitinen et al.
MATURITAS (2004)
Toremifene and tamoxifen are equally effective for early-stage breast cancer:: first results of International Breast Cancer Study Group Trials 12-93 and 14-93
O Pagani et al.
ANNALS OF ONCOLOGY (2004)
Meta-analysis of vascular and neoplastic events associated with tamoxifen
RS Braithwaite et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2003)
Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: A prospective randomized study
M Nystedt et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Evolving uses of hormonal agents for breast cancer therapy
FJ Cummings
CLINICAL THERAPEUTICS (2002)
Cardiovascular effects of tamoxifen in women with and without heart disease: Breast cancer prevention trial
SE Reis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer
A Milla-Santos et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer
K Holli et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Occurrence of stroke with tamoxifen in NSABP B-24
JJ Dignam et al.
LANCET (2000)
Share Paper
